Review Article · e0004

Corn germ oil (Zea mays L.) in the development of dermatological semisolid dosage forms: composition, technological aspects and prospects for application

Full text in three languages: Русский · Қазақша · English

Nagiyeva N.Sh. · ORCID 0009-0008-2033-8267

Kizatova M.Zh. · ORCID 0000-0002-6481-7410

Rakhimova N.A. · ORCID 0000-0003-4950-9951

Ismailova M.M. · ORCID 0000-0002-7394-0103

Yensebayeva G.B. · ORCID 0009-0009-0466-9768

Kurmanaliyeva A.R. · ORCID 0000-0002-1949-099X

Baigaipova G.K. · ORCID 0009-0009-3605-9905

Citation

Nagiyeva N.Sh., Kizatova M.Zh., Rakhimova N.A., Ismailova M.M., Yensebayeva G.B., Kurmanaliyeva A.R., Baigaipova G.K.. Corn germ oil (Zea mays L.) in the development of dermatological semisolid dosage forms: composition, technological aspects and prospects for application. Pharmaceutical Sciences and Health Products. 2026;1(1):e0004.

Abstract

Introduction

Corn germ oil (Zea mays L.) is of interest for the development of dermatological semisolid dosage forms because of its high content of unsaturated fatty acids, tocopherols and phytosterols. Its technological and functional properties depend on the composition of the raw material, the method of production, the degree of purification and oxidative stability.

Objective

To systematize current data on the composition, production methods and pharmaceutically relevant properties of corn germ oil and to assess prospects for its use in the development of dermatological semisolid dosage forms.

Materials and methods

A review of peer-reviewed scientific publications, predominantly from 2017-2026, was performed using PubMed, ScienceDirect, SpringerLink and open-access resources of scientific journals. Data on the composition and production technologies of corn germ oil, its potential dermatological application and Quality by Design (QbD) principles for topical semisolid dosage forms were analyzed.

Results and discussion

Corn germ oil is characterized by a predominance of unsaturated fatty acids, particularly linoleic and oleic acids, and contains tocopherols and phytosterols. Production and purification methods can influence its composition and oxidative stability. Available evidence supports considering the oil as a promising lipophilic component of dermatological semisolid dosage forms, although direct clinical evidence for finished medicinal products remains limited. Based on the literature analysis, key directions for further pharmaceutical development using QbD principles were proposed.

Conclusions

Corn germ oil is a promising component of dermatological semisolid dosage forms. Further application requires standardization of the source raw material and experimental confirmation of the characteristics of the developed formulation.

Keywords

corn germ oilZea mays L.semisolid dosage formsdermatologylinoleic acidtocopherolssupercritical CO₂ extractionQuality by Design

Article history

  1. Published

Peer-review model: Double-blind external peer review · Version: Version of Record

Supplementary materials

No separate supplementary materials.